Cheng Kao

Cheng Kao has a diverse work experience in the field of virology and biochemistry. Cheng is currently working as a Senior Research Fellow at Aligos Therapeutics, where they focus on studying the mechanism of virus replication and developing molecules to inhibit virus replication. Prior to this, they were a Professor in the Molecular Cellular Biochemistry Department at Indiana University from 2009 to 2019.

Before joining Indiana University, Cheng Kao worked as a Visiting Scientist at GlaxoSmithKline Inc from 1999 to 2000. Cheng also served as an Assistant Professor at Indiana University from 1993 to 1999.

Earlier in their career, Cheng Kao was a Postdoctoral Fellow at the University of Wisconsin from 1990 to 1993. During this time, they conducted research on the replication proteins of a positive-strand RNA virus.

Overall, Cheng Kao's work experience showcases their expertise in virology research, with a focus on virus replication mechanisms and the development of antiviral molecules.

Cheng Kao attended Michigan State University from an unknown start year to 1998, where they studied Microbiology. Cheng obtained their degree in 1988, also in Microbiology. During their time at Michigan State University, they pursued a PhD in Microbial Genetics, which they completed in 1988. Although not provided, it is assumed that Cheng Kao also received a degree for their PhD.

Cheng Kao's education history also includes attending the University of Michigan and the University of California, Berkeley. However, the details of their degrees and the exact years of attendance are not provided. At the University of Michigan, they studied Microbiology, and at the University of California, Berkeley, they focused on Molecular Virology. Lastly, Cheng Kao also attended the University of Wisconsin for Molecular Virology, but no further information is available regarding this particular education experience.